Cancer Therapeutics CRC advances promising targets by committing our full suite of infrastructure, equipment and skills to the three phases of early drug discovery and development: hit discovery, lead generation and lead optimisation.
Our Current Pipeline
Commercial Collaborations and Licensing Deals
In specific cases, we will partner with commercial entities to move programs forward into clinical development.
Cancer Therapeutics CRC has executed four preclinical licensing deals and three multi-year research collaborations with pharmaceutical companies.
Partners include the following organisations: